CARDIOVASCULAR ADVERSE EVENTS (CV-AES) IN A POOLED ANALYSIS OF 1090 PATIENTS (PT) FROM PHASE 3 SUNITINIB (SU) TRIALSM. S. Ewer,T. M. Suter,D. J. Lenihan,L. Niculescu,A. Breazna, G. D. Demetri,R. J. MotzerANNALS OF ONCOLOGY(2010)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要